Abstract:Context: Recent studies have demonstrated that baicalin has antihyperglycemic effects by inhibiting lipid peroxidation. Baicalin is low hydrophilic and poorly absorbed after oral administration. Thus, a suitable formulation is highly desired to overcome the disadvantages of baicalin. Objective: The objective of this work was to prepare baicalin-loaded nanostructured lipid carriers (B-NLCs) for enhanced antidiabetic effects. Materials and Methods: B-NLCs were prepared by high-pressure homogenization method using Precirol as the solid lipid and Miglyol as the liquid lipid. The properties of the NLCs, such as particle size, zeta potential (ZP), and drug encapsulation efficiency (EE), were investigated. The morphology of NLCs was observed by transmission electron microscopy. In addition, drug release and antidiabetic activity were also studied. Results: The results revealed that B-NLCs particles were uniformly in the nanosize range and of spherical morphology with a mean size of 92 ± 3.1 nm, a ZP of −31.35 ± 3.08 mV, and an EE of 85.29 ± 3.42%. Baicalin was released from NLCs in a sustained manner. In addition, B-NLCs showed a significantly higher antidiabetic efficacy compared with baicalin. Conclusion: B-NLCs described in this study are well-suited for the delivery of baicalin. SUMMARY Currently, herbal medicines have attracted increasing attention as a complementary approach for type 2 diabetes Baicalin has antihyperglycemic effects by inhibiting lipid peroxidation A suitable formulation is highly desired to overcome the disadvantages (poor solubility and low bioavailability) of baicalin Nanostructured lipid carriers could enhance the antidiabetic effects of baicalin. Abbreviations used: B-NLCs: Baicalin-Loaded Nanostructured Lipid Carriers, B-SUS: Baicalin Water Suspension, EE: Encapsulation Efficiency, FBG: Fasting Blood Glucose, HbAlc: Glycosylated Hemoglobin, HPLC: High-performance Liquid Chromatography; NLCs: Nanostructured Lipid Carriers, PI: Polydispersity Index, SD: Sprague-Dawley, SLNs: Solid lipid nanoparticles, STZ: Streptozotocin, TC: Total cholesterol, TEM: Transmission Electron Microscope, TG: Total Triglyceride, ZP: Zeta Potential.

Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design

Study on technique of preparing baicalin solid lipid nanoparticles by Film-ultrasonic wave dissolving techniques

Nanostructured Lipid Carriers for Oral Delivery of Baicalin: in Vitro and in Vivo Evaluation

Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo

Preparation Optimization of Baicalein Nano-micelles by Box-Behnken Design-Response Method

Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes

Preparation and Rat Intestinal Absorption of Baicalin Solid Lipid Nanoparticles

Optimization of solid lipid nanoparticles of silymarin by using Box-Behnken experimental design

Nanostructured Lipid Carriers Loaded with Baicalin: an Efficient Carrier for Enhanced Antidiabetic Effects.

Preparation and pharmacodynamic evaluation of sodium aescinate solid lipid nanoparticles

Development and evaluation of puerarin-loaded controlled release nanostructured lipid carries by central composite design

Optimization of the Formula for Puerarin Flavonoids Solid Lipid Nanoparticle by Central Design-Response Surface Method

In Vitro Release of Baicalin Solid Lipid Nanoparticles

Optimization and Evaluation of Naringenin Loaded Nanostructured Lipid Carriers

Optimization of protein-loaded nano-liposomes formulation by central composite design and response surface method

Preparation and evaluation of Baicalin-loaded cationic solid lipid nanoparticles conjugated with OX26 for improved delivery across the BBB

Formulation and Characterization of Bufadienolides-Loaded Nanostructured Lipid Carriers

Optimization of Oleanolic Acid Loaded Lactoferrin Nanoparticles Prepara-tion by a Central Composite Design-response Surface Method

Preparation and Characterization of Silybin-Loaded Nanostructured Lipid Carriers

Experiment on Lornoxicam-Loaded Solid Lipid Nanoparticles

Formulation Design, Preparation, and in Vitro and in Vivo Characterizations of Beta-Elemene-Loaded Nanostructured Lipid Carriers